These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Author: Sandberg AA, Rosenthal H, Mittelman A, Murphy GP.
    Journal: Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919.
    Abstract:
    Plasma transcortin and cortisol levels, which are significantly elevated by estrogens, were determinied in a group of patients with prostatic cancer who were on estramustine phosphate (Estracyt) therapy. In a series of 44 male patients studied transcortin and corticol levels became elevated above normal and were maintained at these high levels as long as the patients were on estramustine phosphate therapy. The levels observed in this study may serve as reliable indices to monitor patients who are on this drug.
    [Abstract] [Full Text] [Related] [New Search]